Health Care up on Defensive Bias

Dow Jones

3 hours ago

Health-care companies rose amid deal activity and a rotation back into defensive sectors.

An investment vehicle controlled by Canada's Weston family struck a deal to buy U.K. pharmacy chain Boots from investment firm Sycamore Partners for $8.9 billion including debt. Sycamore separated Boots from former owner Walgreens after a 2025 takeover.

Merck shares fell after the Big Pharma company contended with a legal challenge to its Keytruda oncology drug in Europe. Following a ruling by a Dutch court in a case brought by Halozyme Therapeutics, alleging Merck used the company's MDASE technology, Merck was barred from selling an injectable form of Keytruda in eight European markets, including France, the Netherlands and Sweden.

Becton Dickinson is doubling down on U.S. manufacturing not just to dodge future tariffs, but to strengthen increasingly fragile hospital supply chains, according to Chief Executive Tom Polen.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/news/2673043595"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2673043595\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2673043595?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2673043595","market":"sh","top_or_hot":-1,"title":"Health Care up on Defensive Bias","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose amid deal activity and a rotation back into defensive sectors. \n</p>\n<p>\n  An investment vehicle controlled by Canada's Weston family struck a deal to buy U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. pharmacy chain Boots from investment firm Sycamore Partners for $8.9 billion including debt. Sycamore separated Boots from former owner Walgreens after a 2025 takeover. \n</p>\n<p>\n  Merck shares fell after the Big Pharma company contended with a legal challenge to its Keytruda oncology drug in Europe. Following a ruling by a Dutch court in a case brought by Halozyme <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, alleging Merck used the company's MDASE technology, Merck was barred from selling an injectable form of Keytruda in eight European markets, including France, the Netherlands and Sweden. \n</p>\n<p>\n  Becton Dickinson is doubling down on U.S. manufacturing not just to dodge future tariffs, but to strengthen increasingly fragile hospital supply chains, according to Chief Executive Tom Polen. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Care up on Defensive Bias</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Care up on Defensive Bias\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-10-08 05:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies rose amid deal activity and a rotation back into defensive sectors. \n</p>\n<p>\n  An investment vehicle controlled by Canada's Weston family struck a deal to buy U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. pharmacy chain Boots from investment firm Sycamore Partners for $8.9 billion including debt. Sycamore separated Boots from former owner Walgreens after a 2025 takeover. \n</p>\n<p>\n  Merck shares fell after the Big Pharma company contended with a legal challenge to its Keytruda oncology drug in Europe. Following a ruling by a Dutch court in a case brought by Halozyme <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>, alleging Merck used the company's MDASE technology, Merck was barred from selling an injectable form of Keytruda in eight European markets, including France, the Netherlands and Sweden. \n</p>\n<p>\n  Becton Dickinson is doubling down on U.S. manufacturing not just to dodge future tariffs, but to strengthen increasingly fragile hospital supply chains, according to Chief Executive Tom Polen. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2673043595","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2673043595","pubTimestamp":1791408240,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Health-care companies rose amid deal activity and a rotation back into defensive sectors.An investment vehicle controlled by Canada's Weston family struck a deal to buy U.K. pharmacy chain Boots from investment firm Sycamore Partners for $8.9 billion including debt. Sycamore separated Boots from former owner Walgreens after a 2025 takeover.Merck shares fell after the Big Pharma company contended with a legal challenge to its Keytruda oncology drug in Europe. Following a ruling by a Dutch court in a case brought by Halozyme Therapeutics, alleging Merck used the company's MDASE technology, Merck was barred from selling an injectable form of Keytruda in eight European markets, including France, the Netherlands and Sweden.Becton Dickinson is doubling down on U.S. manufacturing not just to dodge future tariffs, but to strengthen increasingly fragile hospital supply chains, according to Chief Executive Tom Polen.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","IXJ":"全球医疗业ETF-iShares","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","HRTS":"Tema Heart & Health ETF","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","XBI":"SPDR S&P Biotech ETF","BK4007":"制药","SG9999014559.SGD":"United Income Focus Trust Dis SGD","PAWZ":"ProShares Pet Care ETF","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","IYH":"iShares U.S. Healthcare ETF","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","GDOC":"Goldman Sachs Future Health Care Equity ETF","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","IHE":"iShares U.S. Pharmaceuticals ETF","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","FHLC":"Fidelity MSCI Health Care Index","JDOC":"JPMORGAN HEALTHCARE LEADERS ETF","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU1917777945.USD":"安联专题基金Cl AT Acc","BK4534":"瑞士信贷持仓","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","RXL":"ProShares Ultra Health Care","LABU":"三倍做多标普生物-Direxion","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","LU2357627491.SGD":"TRP GLOBAL VALUE EQUITY \"AH\" (SGDHDG) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","FTXH":"First Trust Nasdaq Pharmaceuticals ETF","MRK":"默沙东","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","VHT":"Vanguard Health Care ETF","TRUH":"VanEck Healthcare TruSector ETF","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","BMED":"iShares Health Innovation Active ETF","LU0861579265.USD":"联博低波幅策略股票基金A","PPH":"VanEck Pharmaceutical ETF"},"translate_title":"医疗保健关注防御性偏见","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRUH":0.6,"VHT":0.6,"PAWZ":0.6,"IYH":0.6,"XBI":0.6,"XLV":1.5,"PPH":0.6,"FTXH":0.6,"BMED":0.6,"FHLC":0.6,"JDOC":0.6,"IHE":0.6,"MRK":0.71,"GDOC":0.6,"HRTS":0.6,"RXL":0.6,"LABU":0.6,"IXJ":0.6},"content_text":"Health-care companies rose amid deal activity and a rotation back into defensive sectors. \n\n\n  An investment vehicle controlled by Canada's Weston family struck a deal to buy U.K. pharmacy chain Boots from investment firm Sycamore Partners for $8.9 billion including debt. Sycamore separated Boots from former owner Walgreens after a 2025 takeover. \n\n\n  Merck shares fell after the Big Pharma company contended with a legal challenge to its Keytruda oncology drug in Europe. Following a ruling by a Dutch court in a case brought by Halozyme Therapeutics, alleging Merck used the company's MDASE technology, Merck was barred from selling an injectable form of Keytruda in eight European markets, including France, the Netherlands and Sweden. \n\n\n  Becton Dickinson is doubling down on U.S. manufacturing not just to dodge future tariffs, but to strengthen increasingly fragile hospital supply chains, according to Chief Executive Tom Polen.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}